Columbia Partners L L C Investment Management cut its holdings in shares of Humana Inc. (NYSE:HUM) by 7.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,274 shares of the insurance provider’s stock after selling 1,556 shares during the quarter. Columbia Partners L L C Investment Management’s holdings in Humana were worth $4,939,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of HUM. Creative Planning boosted its position in Humana by 0.3% during the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock worth $1,173,000 after acquiring an additional 15 shares during the last quarter. Bedrijfstakpensioenfonds Voor DE Media PNO purchased a new position in Humana during the second quarter worth about $2,219,000. Sit Investment Associates Inc. raised its stake in Humana by 0.3% during the second quarter. Sit Investment Associates Inc. now owns 12,020 shares of the insurance provider’s stock worth $2,892,000 after purchasing an additional 40 shares during the period. US Bancorp DE raised its stake in Humana by 4.4% during the second quarter. US Bancorp DE now owns 44,359 shares of the insurance provider’s stock worth $10,674,000 after purchasing an additional 1,870 shares during the period. Finally, APG Asset Management N.V. raised its stake in Humana by 64.6% during the second quarter. APG Asset Management N.V. now owns 243,884 shares of the insurance provider’s stock worth $58,683,000 after purchasing an additional 95,673 shares during the period. Hedge funds and other institutional investors own 96.15% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Humana Inc. (HUM) Shares Sold by Columbia Partners L L C Investment Management” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://stocknewstimes.com/2017/11/17/humana-inc-hum-shares-sold-by-columbia-partners-l-l-c-investment-management.html.
Shares of Humana Inc. (NYSE HUM) traded up $2.63 during trading on Friday, hitting $235.91. 2,041,200 shares of the stock traded hands, compared to its average volume of 1,383,548. Humana Inc. has a fifty-two week low of $186.25 and a fifty-two week high of $264.56. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market cap of $33,450.00, a PE ratio of 19.90, a price-to-earnings-growth ratio of 1.60 and a beta of 0.90.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The business had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.41 billion. During the same quarter in the prior year, the business posted $3.18 EPS. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. analysts expect that Humana Inc. will post 11.63 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is 12.60%.
In related news, insider William Kevin Fleming sold 3,071 shares of the stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the completion of the sale, the insider now owns 7,681 shares in the company, valued at approximately $1,927,777.38. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the stock in a transaction on Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The disclosure for this sale can be found here. In the last 90 days, insiders sold 20,660 shares of company stock valued at $5,319,600. Company insiders own 0.80% of the company’s stock.
A number of brokerages have commented on HUM. BMO Capital Markets lifted their target price on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a research note on Friday, November 10th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $242.00 target price (down from $245.00) on shares of Humana in a research note on Thursday, November 9th. Credit Suisse Group reaffirmed an “outperform” rating and set a $260.00 target price (up from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Deutsche Bank AG lifted their target price on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Finally, Oppenheimer Holdings, Inc. lifted their target price on shares of Humana from $236.00 to $255.00 and gave the stock an “outperform” rating in a research note on Thursday, August 3rd. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Humana presently has an average rating of “Hold” and a consensus price target of $252.81.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.